Philips said it took a €363 million provision in the fourth quarter linked to an agreement with the FDA over the recall in the U.S. of its ventilators.
Philips said it took a €363 million provision in the fourth quarter linked to an agreement with the FDA over the recall in the U.S. of its ventilators.